Expertise in
4
conditions

Sergio A. Dib

Sao Paulo, SP, BR 
Expertise in
4
conditions
Sao Paulo, SP, BR 

Overview

Sergio Dib practices practicing medicine in Sao Paulo, Brazil.

Mr. Dib is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Type 1 Diabetes (T1D), Gestational Diabetes, Metabolic Syndrome, and Type 2 Diabetes (T2D).

He is actively involved in clinical research, co-authoring 85 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Sao Paulo, SP, Brazil
Other Locations
Vila Clementino, SP 04021001, Brazil
Paulista, ES, Brazil
Pedro De Toledo, SP 04039001, Brazil

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Double-Blind Study With an Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide With Placebo in Pediatric Patients With Type 2 Diabetes Mellitus (AWARD-PEDS: Assessment of Weekly AdministRation of LY2189265 in Diabetes-PEDiatric Study)
A Randomized, Double-Blind Study With an Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide With Placebo in Pediatric Patients With Type 2 Diabetes Mellitus (AWARD-PEDS: Assessment of Weekly AdministRation of LY2189265 in Diabetes-PEDiatric Study)
Enrollment Status: Completed
Publish Date: July 01, 2022
Intervention Type: Drug
Study Drug: Dulaglutide
Study Phase: Phase 3
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog With an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents With Type 1 Diabetes
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog With an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: January 24, 2022
Intervention Type: Drug
Study Drugs: LY900014, Insulin Lispro
Study Phase: Phase 3
View 1 Less Clinical Trial

85 Total Publications

Development of a low-cost insulin infusion pump software simulator: a case study with a Brazilian company.
Development of a low-cost insulin infusion pump software simulator: a case study with a Brazilian company.
Journal: Journal of medical engineering & technology
Published: September 05, 2025

Frequently Asked Questions about Sergio A. Dib

Is Sergio A. Dib a top-rated expert for Type 1 Diabetes (T1D)?

MediFind is an objective health platform that identifies experts based on real-world data. Sergio A. Dib is classified as an Distinguished expert for Type 1 Diabetes (T1D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sergio A. Dib participate in research or clinical trials?

Yes. Sergio A. Dib has published 85 articles and abstracts on conditions like Type 1 Diabetes (T1D). You can view a list of Sergio A. Dib's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Dib's expertise for a condition
ConditionClose
    View All 20 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile